<scp>STAT6</scp> suppression prevents bleomycin‐induced dermal fibrosisJingjing Huang(Second Affiliated Hospital of Nanjing Medical University), Tingting Mills(The University of Texas Health Science Center)The FASEB JournalJanuary 11, 202310.1096/fj.202200994rCited by 14SaveCiteExport RISWatch citationsRelated PapersLBA12 Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Initial results from a registrational phase II study|Annals of Oncology|2023|10